[Use of captopril in arterial hypertension with a stable and malignant course].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D000328:Adult; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D004232:Diuretics / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000235:genetics; D006977:Hypertension, Renal / Q000188:drug therapy; D006978:Hypertension, Renovascular / Q000188:drug therapy; D007511:Ischemia / Q000139:chemically induced; D007610:Kallikreins / Q000378:metabolism; D007705:Kinins / Q000378:metabolism; D011392:Proline / Q000031:analogs & derivatives*; D051381:Rats; D012079:Renal Circulation / Q000187:drug effects; D012084:Renin-Angiotensin System / Q000187:drug effects; D012964:Sodium / Q000097:blood
D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D007705:Kinins; D011392:Proline; D002216:Captopril; D012964:Sodium; D007610:Kallikreins
Primenenie kaptoprila pri arterial'noĭ gipertonii stabil'nogo i zlokachestvennogo techeniia.